Literature DB >> 8880792

Acute effects of radiofrequency ablation of atrial arrhythmias on implanted permanent pacing systems.

K A Ellenbogen1, M A Wood, B S Stambler.   

Abstract

We studied the safety of performing RF catheter ablation in patients with implanted permanent pacemakers by monitoring the function of implanted pacing systems before, during, and immediately after exposure to RF energy. Patients with implanted pacing systems may require RF ablation for treatment of a variety of tachyarrhythmias. High frequency electromagnetic fields, such as RF energy, may affect implanted pacing systems, causing temporary or permanent loss of output, undersensing, oversensing, asynchronous pacing, or reversion to "reset" (Recommended Replacement Time or Power On Reset) parameters. Thirty-five patients with implanted pacing systems (23 DDDR, 6 VVIR, 5 DDD, 1 VVI, 31 bipolar and 4 unipolar) underwent RF catheter ablation. Prior to ablation, each pacing system underwent measurements of pacing and sensing thresholds, telemetry of intracardiac electrograms and measurement of battery voltage and lead impedance(s). During ablation, pacemaker function was monitored by real-time telemetry, intracardiac electrograms, and surface ECG. Immediately after ablation, each pacing system was reevaluated. Telemetry during RF ablation revealed normal pacing and sensing in 14 (40%) of 35 patients. Refractory period extension with asynchronous pacing and noise mode reversion were seen in 16 (46%) of 35 patients. Rare under- and/or oversensing, reversion to reset parameters, and telemetry "lock up" with inhibition of pacing output was seen in a few patients. After ablation, there were no significant changes in atrial or ventricular pacing or sensing thresholds or measurements of atrial and ventricular lead impedances. We conclude that most permanent pacemakers are not adversely affected by exposure to RF energy during catheter ablation. A variety of pacemaker behaviors may be seen during RF ablation, and a thorough understanding of each pulse generator's potential response(s) to electromagnetic interference is important before undertaking catheter ablation in patients with permanent pacemakers. Careful reevaluation of the patient's pacing system following the procedure is mandatory.

Entities:  

Mesh:

Year:  1996        PMID: 8880792     DOI: 10.1111/j.1540-8159.1996.tb04206.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

1.  Effects of radiofrequency catheter ablation on patients with permanent pacemakers.

Authors:  N Sadoul; I Blankoff; C de Chillou; D Beurrier; M Messier; O Bizeau; I Magnin; B Dodinot; E Aliot
Journal:  J Interv Card Electrophysiol       Date:  1997-11       Impact factor: 1.900

2.  Radiofrequency and Cryo-Ablation Effect on Transvenous Pacing and Defibrillatory Lead Integrity: An In Vitro Study.

Authors:  Yousef H Darrat; Anuj Agarwal; Gustavo X Morales; Joseph Thompson; Ahmed Abdel-Latif; Kelly Waespe; Luigi DI Biase; Andrea Natale; Abhijit Patwardan; Claude-Samy Elayi
Journal:  J Cardiovasc Electrophysiol       Date:  2016-06-14

3.  Effects of external electrical and magnetic fields on pacemakers and defibrillators: from engineering principles to clinical practice.

Authors:  Roy Beinart; Saman Nazarian
Journal:  Circulation       Date:  2013-12-24       Impact factor: 29.690

4.  Twitching of the Pacemaker Pocket Induced by Radiofrequency Energy Delivery to the Cavotricuspid Isthmus.

Authors:  Taku Omori; Eitaro Fujii; Yoshihiko Kagawa; Satoshi Fujita; Tetsuya Kitamura; Masaaki Ito
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

Review 5.  The Effects of Catheter Ablation on Permanent Pacemakers and Implantable Cardiac Defibrillators.

Authors:  Yousef H Darrat; Gustavo X Morales; Claude S Elayi
Journal:  J Innov Card Rhythm Manag       Date:  2017-03-15

Review 6.  Perioperative Management of Patients with Cardiac Implantable Electronic Devices and Utility of Magnet Application.

Authors:  Tardu Özkartal; Andrea Demarchi; Maria Luce Caputo; Enrico Baldi; Giulio Conte; Angelo Auricchio
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.